Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter

Valerie P O'Brien1, Yuqi Kang1, Meera K Shenoy2

  • 1Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington.

PubMed

Insights

Helicobacter pylori infection drives stomach cancer by promoting metaplastic pit cell expansion through inflammation. These cells, found in human gastric cancer, indicate an early step in cancer development.

Area of Science:

  • Gastroenterology and Oncology
  • Microbiology
  • Cell Biology

Background:

  • Mechanisms of Helicobacter pylori (Hp)-driven stomach cancer remain unclear.
  • Hp infection and KRAS activation alter gastric metaplasia and increase inflammation.

Purpose of the Study:

  • To investigate the role of metaplastic pit cells in Hp-driven gastric preneoplasia.
  • To identify the cellular and molecular drivers of Hp-associated gastric cancer.

Main Methods:

  • Utilized a transgenic mouse model with Hp infection and KRAS activation.
  • Employed single-cell RNA sequencing, flow cytometry, and immunohistochemistry.
  • Analyzed human gastric cancer samples for MUC4 expression.

Main Results:

  • Hp+KRAS+ mice developed a metaplastic pit cell population expressing MUC4 and amphiregulin.
  • Metaplastic pit cells were linked to macrophage and T-cell inflammation.
  • Cell expansion was dependent on Hp-driven inflammation and reversed by Hp eradication.
  • MUC4 expression correlated with proliferation in human gastric cancer.

Conclusions:

  • Identified Hp-associated metaplastic pit cells as a precancerous lineage.
  • Hp-driven inflammation promotes expansion of these cells, contributing to gastric cancer.
  • Metaplastic pit cells represent an early step in the gastric metaplasia-to-cancer cascade.

Related Concept Videos

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
705
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
371
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
522
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
632
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
460
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
155